CAR-T cells can kill tumor cells with specific target antigens through active cell lysis and the production of cytokines, including IL-1α, IL-2, IL-6, IL-8, IL-10, and tumor necrosis factor-α (TNF-α) (6, 49). This evidence concerns the gene TNF and neoplasm.